Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
出版年份 2013 全文链接
标题
Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 4, Pages e61537
出版商
Public Library of Science (PLoS)
发表日期
2013-04-20
DOI
10.1371/journal.pone.0061537
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
- (2012) Rabbie K. Hanna et al. GYNECOLOGIC ONCOLOGY
- DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
- (2012) Christopher Korch et al. GYNECOLOGIC ONCOLOGY
- Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression
- (2012) Lingling Dong et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Metformin and cancer therapy
- (2011) Frédéric Bost et al. CURRENT OPINION IN ONCOLOGY
- Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells
- (2011) Zohar Attias-Geva et al. EUROPEAN JOURNAL OF CANCER
- p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy
- (2011) Zohar Attias-Geva et al. EUROPEAN JOURNAL OF CANCER
- Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
- (2011) H Werner ONCOGENE
- The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
- (2011) Rive Sarfstein et al. PLoS One
- The insulin-like growth factor-I receptor as an oncogene
- (2011) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4
- (2010) Jun Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
- (2010) Mahvash Zakikhani et al. BREAST CANCER RESEARCH AND TREATMENT
- Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
- (2010) G. W. D. Landman et al. DIABETES CARE
- Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells
- (2010) Ya Xie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
- (2010) Rive Sarfstein et al. Cancers
- AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress
- (2009) Song Hwa Choi et al. BIOCHEMICAL PHARMACOLOGY
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Targeting the IGF1 axis in cancer proliferation
- (2009) Ilan Bruchim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer
- (2008) M. J. Gunter et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Targeting AMPK: A new therapeutic opportunity in breast cancer
- (2008) Sirwan M. Hadad et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started